News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KemPharm, Inc. Files Antitrust and Other Counterclaims Against Shire plc



3/1/2011 10:11:54 AM

NORTH LIBERTY, Iowa--(BUSINESS WIRE)--KemPharm, Inc. (“KemPharm”) announced today that it has filed an Answer and Counter-Claims against Shire LLC (“Shire”), a subsidiary of Shire plc (LSE: SHP, NASDAQ: SHPGY). KemPharm’s Answer denies the allegations of Shire’s Complaint, raises affirmative defenses, and makes claims for unfair competition, antitrust violations and other relief. The counterclaims were filed in response to a lawsuit filed in Virginia on September 30, 2010, by Shire against KemPharm and Travis Mickle, Ph.D., President and CEO of KemPharm, alleging claims for breach of contract, and intentional interference with contract, related to Dr. Mickle’s prior employment with New River Pharmaceuticals. The antitrust claims assert that the Shire lawsuit is objectively baseless and brought with an improper motive to interfere with KemPharm’s business.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES